Posted in Regulatory and Compliance by Chris Newmarker on May 23, 2016 Nancy Crotti The criminal trial of two former Acclarent executives is set to begin June 7—but the latest example of the U.S. Justice Department cracking down on medical device corporations’ top brass. The government’s case claims that formerAcclarent CEO William Facteau and the firm’s VP […]